It is with great pleasure that we welcome Dr. Victoria Mondloch to Evergrowth’s Medical and Scientific Advisory Board.
Dr. Mondloch is a distinguished OB/GYN physician, consultant, and author, bringing decades of clinical and advisory experience to the table.
We are incredibly fortunate to have her insights and leadership as we continue to grow Evergrowth’s biotech investing initiatives.
Please join me in congratulating Dr. Mondloch on this new chapter with us.
You can learn more about her impressive background here: https://www.linkedin.com/in/victoria-mondloch-md-23b373
Dr. Harvey Tran, Evergrowth BioHealthcare Capital | Evergrowth Enterprises
Follow me on Social Media:
Enjoyed This? Stick Around! Subscribe to my newsletter for more insights on using your MD advantage in biotech investing.
Check out our Fund Presentation and our Skool Community Page.
Disclaimer: This blog is for educational and informational purposes only. It’s not a recommendation to buy, sell, or hold any stock. Always consult your investment advisor and do your due diligence before investing. In working smarter rather than harder, I wrote an initial draft based on my knowledge, experience, and insight. I then leverage AI to put the information together into this presentable format.
More Reads for You:
- Welcoming Dr. Victoria Mondloch to the Evergrowth Medical Advisory Board
- Stop Trading Stocks, Start Owning Businesses
- The Case for Long-Term Biotech Investing: My Story with Jazz Pharmaceuticals
- Red Flags to Spot Pump-and-Dump Schemes: Protect Your Wealth, Docs
- Overcoming Fear in Biotech Investing: How to Thrive Amid Volatility
- Why You Should Pay Attention to Market Cap Size For Smarter Investing
